Biotech Proteintech Welcomes Jeff Lee as Chief Operating Officer
ROSEMONT, Ill.--(BUSINESS WIRE)--Nov 6, 2018--Proteintech, the benchmark in antibodies and proteins, welcomes Jeff Lee as the head of the operations and sales teams. In addition, he will be focusing on fostering new business opportunities.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181106005823/en/
Jeff Lee, Proteintech Chief Operating Officer (Photo: Business Wire)
Jeff Lee comes to Proteintech with 28 years of experience in management and operational roles. At Thermo Fisher Scientific, he has served as Senior Director of Operations for the Clinical Diagnostic Division’s Contract & OEM business unit, General Manager in the Immunoassay Systems SBS and Global Operations Director for Thermo Fisher’s Protein Biology business. Prior to joining Thermo Fisher, Jeff held a variety of operational roles at 3M Company including project engineer, manufacturing operations supervisor, manufacturing manager, and is a six-sigma black belt.
“Jeff Lee is an invaluable addition to Proteintech since his experience and knowledge in the market will enable Proteintech to better serve antibody-users globally,” says Proteintech CEO Jason Li. “His association with Pierce Protein Biotechnology has enabled him to have a wide knowledge of proteins. He knows the significance of the authentic glycosylated human protein and can help deliver Proteintech’s Humankine recombinant protein product line to the research, diagnostic and pharmaceutical markets.”
“I have a clear understanding and deep appreciation for Proteintech’s excellence in antibody and protein production, technical support and customer service,” says new Proteintech COO Jeff Lee. “Proteintech offers a quality and unique antibody to their customers due to its commitment to selling only products made by its own scientists, a unique feat in the current antibody landscape.”
Jeff has broad experience in manufacturing; international operations; project management; global supply chain; quality systems, including cGMP as an FDA-regulated manufacturer; and new product hand-off and scale-up. His previous role’s responsibility for the combined Thermo Fisher and legacy Life Technologies antibody-related business will help with the challenges in the integration of future acquisitions into Proteintech.
About Proteintech Group
Proteintech is an antibody manufacturer selling directly to scientists and only selling its own products to maintain the highest level of quality control leading to superior reproducibility and lot consistency. With over 2/3 of the human genome completed, we have a catalog of over 12,000 antibodies against 12,000 targets covering almost complete spectrum of research areas. With its acquisition of Humanzyme, Proteintech now offers the Humankine product line of animal-free human-cell expressed proteins. To view tens of thousands of publications and in-house validation images in WB, IHC, IF, FC, IP, CHIP, Knock-down siRNA using our antibodies and to learn more about Proteintech and their mission to deliver products directly from their bench to the researcher’s bench, please visit www.ptglab.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20181106005823/en/
CONTACT: Proteintech Group, Inc.
KEYWORD: UNITED STATES NORTH AMERICA ILLINOIS
INDUSTRY KEYWORD: STEM CELLS HEALTH BIOTECHNOLOGY CLINICAL TRIALS GENETICS PHARMACEUTICAL RESEARCH OTHER SCIENCE SCIENCE
Copyright Business Wire 2018.
PUB: 11/06/2018 01:02 PM/DISC: 11/06/2018 01:02 PM